… and bronchus cancer were diagnosed in 2009, and 159,390 deaths (88,900 men; 70,490 …
Only 15% of all lung cancer patients are alive 5 years or more after diagnosis (http://seer.cancer…

… (NSCLC) accounts for the majority of all lung cancer cases. Risk factors for developing NSCLC
… subtypes of lung cancer, small-cell lung carcinoma and non-small-cell lung carcinoma (…

… Drugs approved by the FDA for the treatment of non-small-cell lung cancer. ALK, anaplastic
lymphoma kinase; EGFR, epidermal growth factor receptor; TKIs, tyrosine kinase inhibitors; …

… In the decade since the last Lancet Seminar on lung cancer there have been advances in
many aspects of the classification, diagnosis, and treatment of non-small-cell lung cancer (…

… Important advancements in the treatment of non-small cell lung cancer (NSCLC) have been
achieved over the past two decades, increasing our understanding of the disease biology …

… Most patients with non–small cell lung cancer (NSCLC) are diagnosed with advanced cancer.
… Approximately 85% to 90% of lung cancer cases are caused by cigarette smoking. Active …

… Background: Although the median age at diagnosis of non-small cell lung cancer (NSCLC)
is 70 years, a subset of patients with NSCLC present at a younger age (<40 years). Little is …

… Non-small cell lung cancer accounts for 85% of all lung cancer cases in the United States.
After the initial diagnosis, accurate staging of non-small cell lung cancer using computed …

… has been shown to improve survival in patients with metastatic non-small-cell lung cancer …
of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or …

… for the treatment of advanced non–small cell lung cancer (NSCLC). Initial assessment of a
new patient … findings, which in most cases indicate a nonsquamous or squamous cell subtype. …